Compare ImmunityBio Inc. Common Stock (IBRX) vs The Magnum Ice Cream Company N.V. Ordinary Shares (MICC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs The Magnum Ice Cream Company N.V. Ordinary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.39B), while The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.28 (market cap $10.72B). The key difference: ImmunityBio Inc. Common Stock and The Magnum Ice Cream Company N.V. Ordinary Shares are close in size by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, The Magnum Ice Cream Company N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 6 Days and The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days on average.
| IBRX | MICC | |
|---|---|---|
Market Cap | $10.39B | $10.72B |
Volume | 11,509,049 | 1,309,650 |
Sector | Health | Consumer Staples |
52-Week High | $11.55 | $20.42 |
52-Week Low | $1.98 | $13.06 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $10.84B | $14.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ImmunityBio (IBRX) trades at $9.80, down 3.16% on the day, amid a bullish technical setup and strong analyst support. The company reported revenue growth to $166 million in 2026 but remains deeply unprofitable with a net loss of $992 million. Recent FDA approval expansion for ANKTIVA in bladder cancer and high-profile executive appointments signal operational momentum, though cash burn remains a concern with negative operating cash flow.
Outlook is cautiously optimistic given the unanimous buy ratings and regulatory milestones, but investment carries high risk due to persistent losses, heavy reliance on financing, and competitive pressures. The stock's trajectory hinges on successful commercialization and pipeline execution to achieve profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About The Magnum Ice Cream Company N.V. Ordinary Shares
The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →
